Le Lézard
Classified in: Covid-19 virus

Global Medical Radiation Detection Market (2021 to 2030) - Growing Use of Nuclear Medicine and Radiation Therapy for Diagnosis and Treatment - ResearchAndMarkets.com


The "Medical Radiation Detection Market by Detection Type, Product, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

The global medical radiation detection market was valued at $1,173.0 million in 2020 and is projected to reach $2,558.1 million by 2030, registering a CAGR of 8.4% from 2021 to 2030.

Medical radiation detectors are a type of medical equipment that is used to detect the presence of radiation. When an individual is exposed to radiation for an extended period of time, it is more likely to induce a variety of fatal illnesses. This increases the demand for equipment that can detect the quantity of radiation accumulation in the body. Handheld Survey Meter (HSM), personal radiation detector (PRD), Radiation Portal Monitor (RPM), and Radiation Isotope Identification Device are some of the major detectors available for identifying radioactive materials and ionizing radiation (RIID). With technological advancements, various radiation detecting gadgets may become accessible for use at home. Dosimeters are medical radiation detecting equipment that can detect the presence of Gamma rays, the most dangerous external radioactive threat.

The rising occurrence of cancer necessitates the use of medical radiation detectors, which drives the market expansion. Furthermore, an increase in the use of nuclear medicine and radiation therapy for the diagnosis and treatment of acute radiation illness will contribute to market growth in the future. Furthermore, there has been a significant increase in the number of diagnostic imaging facilities that require medical radiation detectors to avoid excessive radiation exposure, fuelling the market development throughout the projection period.

Rising awareness regarding safety from prolonged exposure to radiation especially in radiation-prone settings as well as an increase in the number of individuals having medical insurance would propel the growth of the medical radiation market during the forecast period. However, the increased cost of medical radiation detection will stifle the market expansion. Furthermore, the increased potential for medical radiation detection in emerging markets is expected to assist the industry produce more possibilities in the coming years.

The global medical radiation detection market is segmented on the basis of detection type, product, end user, and region. On the basis of detection type, the market is categorized into gas-filled detectors, scintillators, and solid-state. By product, it is classified into personal dosimeters, area process dosimeters, surface contamination monitors, and others. By end user, it is divided into hospitals, ambulatory surgical centers, clinics, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Based on detection type, the market is categorized into gas-filled detectors, scintillators, and solid-state. In addition, the gas-filled detectors segment is expected to gain the highest revenue during the forecast period. This is attributed to spike in demand for gas-filled detectors to aid in the control of severe radiation exposure. In addition, the improvement in usage of nuclear medicines would propel the market growth in the coming years.

Based on product, the personal dosimeters segment is anticipated to gain the fastest CAGR during the forecast period, owing to the benefits of personal dosimeters, including an alert system for radiation exposure throughout the day and the availability of indications that aid in detecting increased sensitivity to hazardous radiation. However, area process dosimeters are expected to gain a significant share during the forecast period. This is attributed to the rising need for such dosimeters for detecting hazardous radiation in the commenced period.

Based on end user, the market is divided into hospitals, ambulatory surgical centers, clinics, and others. The hospitals segment is anticipated to gain the fastest CAGR during the forecast period, owing to a surge in the number of outpatients and inpatients in hospitals as well as an increase in patient population during the forecast period. In addition, the clinics segment is expected to gain significant share, owing to the ease in accessibility of clinics in remote areas, thereby propelling the market growth.

Market Dynamics

Drivers

Restraint

Opportunities

Impact Analysis

Companies Mentioned

Key Market Segments

By Detection Type

By Product

By End User

By Region

For more information about this report visit https://www.researchandmarkets.com/r/6ccjaj


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 04:33
Uxin Limited ("Uxin" or the "Company") , China's leading used car retailer, today announced its unaudited financial results for the third quarter ended December 31, 2023. Highlights for the Quarter Ended December 31, 2023 Transaction volume was...

at 03:45
Phoenix Motor Inc. (the "Company"), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced it signed a waiver agreement with JAK Opportunities II LLC, one of the...

at 03:05
Vagaro, the leading international salon and spa software, and Jack Mead, award-winning hair stylist, salon owner, and educator, officially announced the release of their highly-anticipated Master Class series, delivering expert insights on using the...

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...



News published on and distributed by: